| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.04. | Cognito Therapeutics moves to drop 'dementia' from its comms, scientific materials | ||
| 08.04. | Invivyd launches 'Antibodies for Any Body' campaign with Olympic skier Lindsey Vonn | ||
| 08.04. | Insmed terminates development of Brinsupri in another indication after midstage HS flop | ||
| 07.04. | With Gardasil demand shortfall in China, Merck and Zhifei adjust their partnership | ||
| 07.04. | Vertex taps Halozyme and its recently acquired Elektrofi tech in $15M drug delivery deal | ||
| 07.04. | FDA seeks legislative teeth to bite back against misleading DTC drug ads | ||
| 06.04. | ImmunityBio responds to FDA scrutiny over Anktiva promotional claims with new protocols | ||
| 06.04. | Insulet's Omnipod takes Type 2 diabetes representation to the TV screen in 'Scrubs' revival | ||
| 06.04. | Neurocrine, eying 'blockbuster in the making,' strikes its largest-ever M&A deal with $2.9B Soleno buyout | ||
| 06.04. | Amgen scores with trial of on-body injected version of Tepezza in thyroid eye disease | ||
| 06.04. | VML Health urges marketers to shift from lifespan to 'joyspan' as patient goals evolve | ||
| 06.04. | Eli Lilly takes the court with 150th anniversary campaign to catch Final Four crowd | ||
| 03.04. | An update on the pharma industry's reshoring effort | ||
| 02.04. | Trump slaps 100% duties on imported drugs but leaves plenty of exceptions | ||
| 02.04. | UK signs off on US pharma deal, ensuring tariff reprieve as Britain aims to reattract investments | ||
| 02.04. | BioNTech telegraphs closure of Singapore vaccine facility amid efforts to 'align capacity' | ||
| 02.04. | Rising Stars: The Trade Desk's Elizabeth Keenan finds the rhythm in music and media | ||
| 02.04. | Trump eyes 100% tariff rate for companies that have not struck MFN deals: Bloomberg | ||
| 02.04. | Poland, Romania must pay Pfizer $2.2B in fight over contested COVID vaccine doses: Belgian court | ||
| 02.04. | Lilly's obesity pill Foundayo gains early blockbuster forecast as analysts float 5M+ prescriptions in 2026 | ||
| 02.04. | Another AstraZeneca Emerald glimmers as Imfinzi, Imjudo delay liver cancer progression | ||
| 02.04. | Glenmark goes direct with new US Ryaltris marketing plan as it drops partner model | ||
| 02.04. | German CDMO Adragos buys French sterile injectables plant from Sanofi | ||
| 02.04. | Bayer rejigs marketing claims after recommendation from US advertising body | ||
| 02.04. | Regulatory tracker: Vertex secures broader FDA labels for cystic fibrosis meds Alyftrek, Trikafta |